Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › AZN

GLENVIEW CAPITAL MANAGEMENT, LLC position in AZN

ASTRAZENECA PLC · Health Care

GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 125,678 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$20.3M, representing 0.36% of its reported portfolio and ranking #43 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed AZN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)125.68K sh
Reported value held$20.29M
Portfolio Weight0.36%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How GLENVIEW CAPITAL MANAGEMENT, LLC's AZN position evolved

GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in AZN in Q2 2026 at 184,279 shares (US$34.9M). Across 2 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 125,678 shares valued at US$20.3M — a reduction of -58,601 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 184.28K $34.94M New
Q3 2026 125.68K $20.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 58 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$8.33B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has GLENVIEW CAPITAL MANAGEMENT, LLC held AZN?

GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed AZN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in AZN?

As of Q3 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 125.68K shares of AZN (ASTRAZENECA PLC), valued at $20.29M, representing 0.36% of its reported portfolio and ranking #43.

Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling AZN?

In the latest 13F filing (Q3 2026), GLENVIEW CAPITAL MANAGEMENT, LLC reduced its position in AZN.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.